Literature DB >> 25579888

Reconstitution of natural killer cells in HLA-matched HSCT after reduced-intensity conditioning: impact on clinical outcome.

Caroline Pical-Izard1, Roberto Crocchiolo2, Samuel Granjeaud1, Eloise Kochbati1, Sylvaine Just-Landi1, Christian Chabannon3, Coralie Frassati4, Christophe Picard4, Didier Blaise5, Daniel Olive1, Cyril Fauriat6.   

Abstract

Recent advances in the development of reduced-intensity conditioning (RIC) have allowed a broader range of patients to access allogeneic hematopoietic stem cell transplantation (HSCT). Reconstitution of an effective immune system post-transplant, including natural killer (NK) cells, is critical for both tumor control and infectious disease control or prevention. The development and functions of NK cells in such settings remain elusive. Here we analyzed NK cell development in HLA-matched HSCT from related or unrelated donors, after RIC that included antithymocyte globulin (N = 45 patients). Our data reveal that NK cells quickly recover after RIC-HSCT, irrespective of donor type. Rapidly re-emerging NK cells, however, remain immature for more than 6 months. Effector functions resemble that of immature NK cells because they poorly produce IFN-γ and TNF-α in response to target cell stimulation, despite a rapid acquisition of degranulation ability and MIP-1β production. Strikingly, rapid reconstitution of cytokine production correlates with a lower relapse incidence (P = .01) and a better survival rate (P < .0001) at 1 year post-transplant, whereas degranulation capacity was associated with less relapse (P = .05). Our study demonstrates rapid quantitative reconstitution of the NK cell compartment despite administration of potent immune suppressive drugs as part of the conditioning regimen and after transplantation. However, there is a prolonged persistence of functional defects, the correction of which positively correlates with clinical outcome.
Copyright © 2015 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HLA-matched; NK cells; NK functions; Reduced-intensity conditioning; Stem cell transplantation

Mesh:

Substances:

Year:  2015        PMID: 25579888     DOI: 10.1016/j.bbmt.2014.11.681

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  24 in total

1.  New insights into effective targeted therapy for the treatment of adult acute lymphoblastic leukemia.

Authors:  Xavier Thomas
Journal:  Int J Hematol Oncol       Date:  2017-05-18

2.  NK-cell activation is associated with increased HIV transcriptional activity following allogeneic hematopoietic cell transplantation.

Authors:  Louise E Hogan; Christian Körner; Kristen Hobbs; Camille R Simoneau; Cassandra Thanh; Erica A Gibson; Christine D Palmer; Alisha Pandit; Francisco M Marty; Daniel R Kuritzkes; Stephanie Jost; Jerome Ritz; Timothy J Henrich
Journal:  Blood Adv       Date:  2018-06-26

3.  Fewer Circulating Natural Killer Cells 28 Days After Double Cord Blood Transplantation Predicts Inferior Survival and IL-15 Response.

Authors:  Rachel J Bergerson; Robin Williams; Hongbo Wang; Ryan Shanley; Gretchen Colbenson; Alyssa Kerber; Sarah Cooley; Julie Curtsinger; Martin Felices; Jeffrey S Miller; Michael R Verneris
Journal:  Blood Adv       Date:  2016-10-30

4.  Robust CD4+ T-cell recovery in adults transplanted with cord blood and no antithymocyte globulin.

Authors:  Ioannis Politikos; Jessica A Lavery; Patrick Hilden; Christina Cho; Taylor Borrill; Molly A Maloy; Sergio A Giralt; Marcel R M van den Brink; Miguel-Angel Perales; Juliet N Barker
Journal:  Blood Adv       Date:  2020-01-14

5.  Flow Cytometry-based Assay for the Monitoring of NK Cell Functions.

Authors:  Sara Tognarelli; Benedikt Jacobs; Nina Staiger; Evelyn Ullrich
Journal:  J Vis Exp       Date:  2016-10-30       Impact factor: 1.355

6.  Low incidence of severe cGvHD and late NRM in a phase II trial of thymoglobulin, tacrolimus and sirolimus for GvHD prevention.

Authors:  Z Al-Kadhimi; Z Gul; M Abidi; L G Lum; A Deol; W Chen; H Jang; C Ozust; A Langston; E Waller; J Uberti
Journal:  Bone Marrow Transplant       Date:  2017-06-05       Impact factor: 5.483

7.  "Uncovering" the recovery of natural killer cells after reduced-intensity conditioning transplantation.

Authors:  Veronika Bachanova
Journal:  Biol Blood Marrow Transplant       Date:  2015-01-20       Impact factor: 5.742

8.  Glycolytic requirement for NK cell cytotoxicity and cytomegalovirus control.

Authors:  Annelise Y Mah; Armin Rashidi; Molly P Keppel; Nermina Saucier; Emily K Moore; Joshua B Alinger; Sandeep K Tripathy; Sandeep K Agarwal; Emily K Jeng; Hing C Wong; Jeffrey S Miller; Todd A Fehniger; Emily M Mace; Anthony R French; Megan A Cooper
Journal:  JCI Insight       Date:  2017-12-07

9.  Influence of donor KIR genotypes on reduced relapse risk in acute myelogenous leukemia after hematopoietic stem cell transplantation in patients with CMV reactivation.

Authors:  Ryotaro Nakamura; Ketevan Gendzekhadze; Joycelynne Palmer; Ni-Chun Tsai; Sally Mokhtari; Stephen J Forman; John A Zaia; David Senitzer; Guido Marcucci; Anthony Stein
Journal:  Leuk Res       Date:  2019-09-28       Impact factor: 3.156

Review 10.  Immune function in childhood cancer survivors: a Children's Oncology Group review.

Authors:  Gregory M T Guilcher; Linda Rivard; Jennifer T Huang; Nicola A M Wright; Lynette Anderson; Hesham Eissa; Wendy Pelletier; Shanti Ramachandran; Tal Schechter; Ami J Shah; Ken Wong; Eric J Chow
Journal:  Lancet Child Adolesc Health       Date:  2021-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.